Galectin‐4 functions as a tumor suppressor of human colorectal cancer
Open Access
- 9 November 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (4), 799-809
- https://doi.org/10.1002/ijc.25750
Abstract
Development of colorectal cancer (CRC) involves a series of genetic alterations with altered expression of proteins and cell signaling pathways. Here, we identified that galectin‐4 (gal‐4), a marker of differentiation, was down‐regulated in CRC. The goal of this work was to determine the function of gal‐4 in CRC. Toward this goal, the human colon biopsies and tissue microarrays containing a gradient of pathology were analyzed for gal‐4 expression by immunohistochemistry. Cell proliferation, migration, motility, forced expression, knockdown, cell cycle and apoptosis assays were used to characterize gal‐4 function. Immunohistochemistry identified that gal‐4 expression was significantly down‐regulated in adenomas and was essentially absent in invasive carcinomas. Forced expression of gal‐4 in gal‐4 −ve cells induced cell cycle arrest and retarded cell migration and motility. Further, gal‐4 sensitized the cells to camptothecin‐induced apoptosis. Gal‐4 knockdown resulted in increased cell proliferation, migration and motility. Gal‐4 was found to be associated with Wnt signaling proteins. Finally, gal‐4 expression led to down‐regulation of Wnt signaling target genes. This study demonstrates that loss of gal‐4 is a common and specific event in CRC. This study also shows that gal‐4 exhibits tumor suppressive effects in CRC cells in vitro . Through its ability to interact with and down‐regulate the functions of Wnt signaling pathway, gal‐4 reveals a new dimension in the control of the Wnt signaling pathway. Thus, gal‐4 may prove to be an important molecule in understanding the biology of CRC.This publication has 42 references indexed in Scilit:
- Cancer stem cells from colorectal cancer-derived cell linesProceedings of the National Academy of Sciences of the United States of America, 2010
- Mutations in the Human naked cuticle Homolog NKD1 Found in Colorectal Cancer Alter Wnt/Dvl/β-Catenin SignalingPLOS ONE, 2009
- Gene expression profiling in sinonasal adenocarcinomaBMC Medical Genomics, 2009
- RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathwaysProteomics, 2009
- Genetic Progression and the Waiting Time to CancerPLoS Computational Biology, 2007
- Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factorsProceedings of the National Academy of Sciences of the United States of America, 2007
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Inflammation and cancerNature, 2002
- β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinBCell, 2002
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002